Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT03453567
Active, not recruiting Observational

Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice

NCT03453567 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seung-Jung Park
Phase
Observational
Started
2018-05-10
Last updated
2026-01-02

Condition(s) studied

Aortic Valve DiseaseAortic Valve Stenosis

Investigational drug(s) / intervention(s)

Valve Replacement

Valve Replacement: Aortic valve replacement

Study summary

This study evaluated effectiveness and safety of aortic valve replacement in real-world clinical practice.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age 19 and more * Patient with aortic valve replacement Exclusion Criteria: * Combined with mitral stenosis requiring surgery or aorta stenosis * Acute bacterial endocarditis within 1 month of valve replacement

Primary outcome measure(s)

  • All-cause death — 1 year

Trial sites (3)

FacilityCityRegionStatus
Sejong Hospital Bucheon-si South Korea
Asan Medical Center Seoul South Korea
Pusan National University Yangsan Hospital Yangsan South Korea

More Seung-Jung Park trials in South Korea

Study of the Natural History of FFR Guided Percutaneous Coronary Intervention Recruiting
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice Recruiting
Observational Study for Left Main Disease Treatment Recruiting
Asan Multivessel Registry Recruiting
IRIS-Onyx Cohort in the IRIS-DES Registry Active, not recruiting

Other trials for the same condition

CHATEAU Registry: Clinical Outcomes After Transcatheter Aortic Valve Replacement Recruiting
Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice Starting soon
Lipoprotein(a) and Progression of Aortic Stenosis Active, not recruiting
ASAN Medical Center Aortic Valve Replacement Registry Active, not recruiting
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03453567 on ClinicalTrials.gov ↗ ← All trials in South Korea